In Regard to Wages et al and Leite et al

Affiliations

Comment

Claudio Fiorino et al. Int J Radiat Oncol Biol Phys. 2021.

. 2021 Aug 1;110(5):1548-1549.

doi: 10.1016/j.ijrobp.2021.04.045.

No abstract available

Comment in

In Reply to Fiorino et al.
Leite ETT, Ramos CCA, Moraes FY. Leite ETT, et al. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1549-1550. doi: 10.1016/j.ijrobp.2021.04.046. Int J Radiat Oncol Biol Phys. 2021. PMID: 34273333 No abstract available.

Hypofractionated Postprostatectomy Radiation Therapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase 1/2 Trial.
Wages NA, Sanders JC, Smith A, Wood S, Anscher MS, Varhegyi N, Krupski TL, Harris TJ, Showalter TN. Wages NA, et al. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1254-1262. doi: 10.1016/j.ijrobp.2020.11.009. Epub 2020 Nov 21. Int J Radiat Oncol Biol Phys. 2021. PMID: 33227441 Free PMC article. Clinical Trial.
Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial.
Leite ETT, Ramos CCA, Ribeiro VAB, Salvajoli BP, Nahas WC, Salvajoli JV, Ynoe Moraes F. Leite ETT, et al. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1263-1270. doi: 10.1016/j.ijrobp.2020.12.020. Epub 2020 Dec 17. Int J Radiat Oncol Biol Phys. 2021. PMID: 33346091 Clinical Trial.